OrbiMed Advisors
http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.
View Older Stories View More Recent Stories
-
Form SC 13D/A SYNLOGIC, INC. Filed by: ORBIMED ADVISORS LLC
-
Cydan Appoints Chief Business Officer
-
Form 4 ORBIMED ADVISORS LLC For: Mar 27 Filed by: Adaptimmune Therapeutics PLC
-
Form SC 13D/A Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC
-
Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2017 Financial Results
-
PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer
-
Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
-
Form 4 ORBIMED ADVISORS LLC For: Mar 12 Filed by: Corvus Pharmaceuticals, Inc.
-
WallachBeth Capital, LLC Acts as the Sole Placement Agent for SmartZyme's Ongoing Series B-1 Offering
-
Natera Reports Fourth Quarter and Fiscal Year 2017 Financial Results
-
Form 4 ORBIMED ADVISORS LLC For: Mar 08 Filed by: Audentes Therapeutics, Inc.
-
Form 4 ORBIMED ADVISORS LLC For: Mar 02 Filed by: GLAUKOS Corp
-
Form 4 ORBIMED ADVISORS LLC For: Mar 02 Filed by: Audentes Therapeutics, Inc.
-
Form SC 13D/A ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form 4 Xtant Medical Holdings, For: Feb 14 Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A PIERIS PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A Intellia Therapeutics, Filed by: ORBIMED ADVISORS LLC
-
Form 4 ORBIMED ADVISORS LLC For: Feb 13 Filed by: PIERIS PHARMACEUTICALS, INC.
-
Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
-
Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
-
Form SC 13G/A Xenon Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A SYNERGY PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G Sierra Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A Wright Medical Group Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A ObsEva SA Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A ProQR Therapeutics N.V. Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A NEWLINK GENETICS CORP Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A ROCKET PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A IOVANCE BIOTHERAPEUTICS, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A Insys Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A INFINITY PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A IMMUNOGEN INC Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A INSMED Inc Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A IMMUNOMEDICS INC Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A FLUIDIGM CORP Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A eHealth, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A GLAUKOS Corp Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A Audentes Therapeutics, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A Cellectis S.A. Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A Aeglea BioTherapeutics, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A ARRAY BIOPHARMA INC Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: ORBIMED ADVISORS LLC
-
Xtant Medical Announces Results of Special Meeting of Stockholders
-
Form 4 ORBIMED ADVISORS LLC For: Feb 08 Filed by: Kala Pharmaceuticals, Inc.
-
Form SC 13D ARMO BioSciences, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A RHYTHM PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
-
Form 4 ORBIMED ADVISORS LLC For: Feb 02 Filed by: Kala Pharmaceuticals, Inc.
-
Form 4 ORBIMED ADVISORS LLC For: Jan 31 Filed by: Kala Pharmaceuticals, Inc.
